Review and reduction of cross-shareholdings based on ROIC and business necessity
First written in FY2019. 8 of 16 entries say "Advanced", first in FY2020. Latest entry: FY2027-H1.
- FY2027-H1AdvancedAnnual report
「The company completed the sale of the shares in May 2026. The group decided to sell some listed shares held for pure investment purposes in order to improve the efficiency of its assets. Among the shares whose sale had been decided, those scheduled for sale within one year as of the end of the current interim consolidated accounting period are classified as held for sale.」
Regarding the reduction of cross-shareholdings, the company completed the sale of its shares in CHIMEI Corporation in May 2026. It also announced a policy of selling some listed shares held for pure investment purposes to improve asset efficiency. - FY2026AdvancedAnnual report
「Unlisted shares 11 1,538 Shares other than unlisted shares 4 823」
For cross-shareholdings, Mitsubishi Chemical reviewed their economic rationale based on ROIC and their business necessity, and reduced the number of shares held in 11 unlisted issues and 4 listed issues. - 2026-05-13MitigatedFinancial results presentation
「Improvement in inventory valuation gains and losses as the decline in raw-material prices leveled off」
Inventory valuation gains and losses deteriorated in Materials & Polymers but improved in Carbon as the decline in raw-material prices leveled off, with the overall result improving from a loss of ¥7.2 billion in the same period of the previous year to a loss of ¥4.0 billion. - FY2025AdvancedAnnual report
「Unlisted shares 3 900 Shares other than unlisted shares 5 120」
Continuing to review economic rationale based on ROIC and business necessity, Mitsubishi Chemical reduced its holdings in 3 unlisted issues and 5 listed issues during the fiscal year. - FY2025-H1RestatedAnnual report
「The group continuously reviews the strategic significance of its cross-shareholdings. Among the holdings whose sale was decided because they were deemed to have limited strategic significance, shares scheduled for sale within one year as of the end of the previous consolidated fiscal year are classified as held for sale.」
The company continued to disclose its ongoing review of the strategic significance of cross-shareholdings and the classification of holdings whose sale had been decided as held for sale. - FY2024AdvancedAnnual report
「As a result of the review, the company confirmed that some holdings had limited strategic significance and is proceeding with their sale while taking into consideration the impact on the market and other factors.」
Continuing to review cross-shareholdings based on ROIC and business necessity, Mitsubishi Chemical reduced the number of shares held in 8 unlisted issues and 5 listed issues. - FY2024-Q3RestatedAnnual report
「The sales had not been completed as of the end of the third quarter of the current consolidated fiscal year.」
The company stated that the sale of cross-shareholdings deemed to have limited strategic significance had not been completed even as of the end of the third quarter. - FY2024-Q2RestatedAnnual report
「The sales had not been completed as of the end of the second quarter of the current consolidated fiscal year.」
The company stated that, as of the quarter-end, the sale remained incomplete for residual shares classified as held for sale among the cross-shareholdings whose sale had been decided based on a review of their strategic significance. - FY2023AdvancedAnnual report
「The number of shares was reduced for 10 unlisted issues and 9 issues other than unlisted shares.」
Continuing to review cross-shareholdings based on ROIC and business necessity, Mitsubishi Chemical sold 10 unlisted issues and 9 listed issues. - FY2023-Q3AdvancedAnnual report
「Although we are proceeding with sales sequentially, the sales had been largely completed as of the end of the third quarter of the current consolidated fiscal year.」
The company stated that it had proceeded with the sale of cross-shareholdings deemed to have limited strategic significance and had substantially completed the sales as of the end of the third quarter. - FY2022AdvancedAnnual report
「Unlisted shares 11 242 Shares other than unlisted shares 14 5,091」
Continuing to review economic rationale based on ROIC and business necessity, Mitsubishi Chemical reduced its holdings in 11 unlisted issues and 14 listed issues during the fiscal year. - FY2020AdvancedAnnual report
「At its Board of Directors meeting on 30 August 2019, the company reviewed the significance of all investment securities held by the group as of the end of March 2019 for purposes other than pure investment, from the perspectives of economic rationale based on ROIC (return on invested capital) and business necessity, among others.」
The company stated that it continued to review holdings based on ROIC and business necessity, and that Mitsubishi Chemical had sold 10 unlisted holdings and 14 listed holdings. - FY2019First statedAnnual report
「At a meeting of the Board of Directors held on 30 August 2018, we reviewed the significance of holding all investment shares held by our Group as of the end of March 2018 for purposes other than pure investment, from the perspectives of economic rationality based on ROIC (return on invested capital), business necessity and other factors. As the review confirmed that certain shares had little significance to the company, we are proceeding with their sale while taking into consideration the potential impact on the market and other factors.」
For cross-shareholdings, the company reviewed their economic rationale based on ROIC and their business necessity, and presented for the first time, as a separate topic, its policy of selling holdings deemed to have limited strategic significance.